Janssen Sciences Ireland UC has announced an expansion of its Ringaskiddy, Co. Cork facility. This will allow it to meet the critical needs of patients around the world. There will be an investment of more than €300 million that will increase the existing manufacturing space by an additional 19,100m2. And envisages to employ a further 200 people.
Construction on the Janssen Sciences Ireland UC expansion is expected to take approximately two years, beginning in October 2017. On average, up to 450 people will be employed during the construction period.
Janssen Sciences Ireland UC manufactures products indicated for the treatment of conditions that include rheumatoid arthritis, psoriasis and cancer. Established in 2005, there are 555 people working at the Ringaskiddy, Co. Cork facility. In 2016 the company became the first pharmaceutical manufacturing company in Ireland to receive the Business Working Responsibly Mark for its commitment and activity towards creating responsible and sustainable business practices.
Source: IDA Ireland